Sort   by:  
 Page size 
UnknownClinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.
Not available
S-EPMC6830509 | biostudies-literature
UnknownPredictive Model for High-Risk Coronary Artery Disease.
Not available
S-EPMC6368397 | biostudies-literature
UnknownLipopolysaccharide confinement in the bacterial outer membrane is governed by interactions within the conserved Lipid A anchor
Not available
S-SCDT-10_1038-S44318-026-00711-5 | biostudies-other
UnknownNatriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.
Not available
S-EPMC6719723 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownEmpagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7614055 | biostudies-literature
Sort   by:  
 Page size